Neuronetics
Medical technology company developing transcranial magnetic stimulation (TMS) devices
Last updated August 26, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Neuronetics is a medical technology company focused on developing transcranial magnetic stimulation (TMS) devices for treating major depressive disorder and other psychiatric conditions. Its flagship product, NeuroStar Advanced Therapy, is FDA-approved and used globally. Founded in 2003, headquartered in Malvern, Pennsylvania, and listed on NASDAQ.
Products and positioning
professional, clinically validated, innovative
Product categories. NeuroStar Advanced Therapy · TMS 设备
Recent events
- 2008
Neuronetics announces FDA clearance for NeuroStar TMS[1]
Regulation
Neuronetics 的 NeuroStar TMS 系统获得 FDA 批准,用于治疗重度抑郁症。
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/neuronetics · Editorial policy · How profiles are compiled